Mark D. Shen, Ph.D.

Principal Investigator

Co-Director of the CIDD Clinical Trials Program

Dr. Shen is a developmental neuroscientist and Assistant Professor (tenure-track) at UNC School of Medicine, with appointments in Psychiatry, Neuroscience Center, and the CIDD. Dr. Shen published the first MRI study to longitudinally measure brain growth trajectories in infants before they were diagnosed with autism. Additionally, his lab replicated (in three studies) the consistent finding that infants and toddlers diagnosed with autism had excessive cerebrospinal fluid (CSF) surrounding the brain by 6 months of age, preceding behavioral symptoms. His lab compares/contrasts the brain growth trajectories of autism, fragile X syndrome, and Angelman syndrome — to detect the earliest symptoms and identify potential therapeutic targets – with the goal of designing the most effective clinical trials.

The lab’s research has received numerous recognitions. For two consecutive years, Dr. Shen’s papers were ranked as “Top 10 Papers of the Year” by Autism Speaks. Eight of the lab’s papers were nominated by NIH as finalists in their annual report of “the most significant advances in autism research”. Dr. Shen was named the Early Career Investigator of the Year in 2018 by the International Society for Autism Research.

Dr. Shen completed his Ph.D. at the UC Davis MIND Institute and his postdoctoral fellowship at UNC. He serves on the Executive Committee, Genetics Core, and MRI Core of the Infant Brain Imaging Study, or IBIS (an NIH Autism Center of Excellence). Prior to his research career, he worked for 6 years as a clinician with young children and adults with developmental disabilities — where the many abilities of these individuals inspired him to conduct research that could help them achieve their greatest potential and quality of life.


Zumin Chen, Ed.M, B.A.

Lab Manager & Study Coordinator

Zumin coordinates the lab’s research studies and joined the lab since 2023. He earned his master’s degree in Human Development and Education at Harvard Graduate School of Education and majored in psychology and cognitive science at the University of Virginia. He is passionate about uncovering the neural mechanisms that underlie typical and atypical development in children. His goal is to become a prominent researcher in the field of developmental psychology and neuroscience with a focus on early childhood through pursuing a Ph.D. in the future. Outside of the lab, Zumin is a big foodie and loves to try new restaurants whenever he can. Learn more about Zumin through his website.


Dea Garic, Ph.D.

Research Assistant Professor

Dr. Garic is a Research Assistant Professor at UNC and recipient of a 5-year K01 Career Development Award from NIH. She was previously a Postdoctoral Fellow in the Shen Lab in the NIH-funded T32 training program at the CIDD. She earned her Ph.D. in Developmental Neuroscience-Psychology at Florida International University. She is mentored by Dr. Shen, and her current research is centered on identifying early neural features associated with the pathogenesis and symptomatic progression of neurodevelopmental disabilities, including Down syndrome.


Renée Elizabeth Mayfield B.S.

Research Assistant

Renée is the research coordinator for the infant Down syndrome study. She earned dual degrees (B.S. in Biology and B.S. in Psychology) with highest distinction and highest honors in Biology from UNC-Chapel Hill in 2024. She works directly with families through recruitment, enrollment, and scheduling research visits. She also acquires MRI scans for these babies during natural sleep and helps analyze the resulting data. In her free time, Renée loves running, spending time with her family, and volunteering in the children's ministry at her church.


Jamie Capal, M.D.

Co-Director of the CIDD Clinical Trials Program

UNC Associate Professor of Pediatrics and Neurology

Dr. Capal is a neurodevelopmental neurologist with a clinical and research focus on neurodevelopmental disabilities across the lifespan. Her lab is interested in expanding complementary pre-clinical studies relevant to developing therapeutics for rare neurodevelopmental disabilities. Currently, Dr. Capal is leading several clinical trials in Angelman syndrome, fragile X syndrome, and Tuberous Sclerosis Complex. Dr. Capal and Dr. Shen are Co-Directors of the CIDD Clinical Trials Program.


Hannah Riehl, M.A.

Clinical Trials Program Manager

Hannah manages the CIDD Clinical Trials Program, co-directed by Dr. Shen and Dr. Capal. Hannah earned her Master’s degree in Child Study and Human Development with concentrations on neuroscience and clinical psychology from Tufts University in 2020.


Caisi Hecht, B.A.

Clinical Trials Associate

Caisi assists with coordinating and conducting participant visits for clinical trials at the Carolina Institute of Developmental Disabilities. Caisi graduated from Marist College in 2020 with a B.A. in Psychology and a minor in Cognitive Science, and she has plans to continue her education in the field of psychology. She thoroughly enjoys working with children and families and bringing them specialized opportunities through clinical research.


Graduate Students

Siddhi Ozarkar: UNC Ph.D. student in Neuroscience (co-mentored with Ben Philpot).

Felix Kyere: UNC Ph.D. student in Neuroscience; T32 Predoctoral Fellow in Translational Medicine, co-mentored by Jason Stein and Mark Shen.

Ian Curtin: UNC Ph.D. student in Genetics; T32 Predoctoral Fellow in Translational Medicine, co-mentored by Jason Stein and Mark Shen.

Elissavet Chartampila: UNC Ph.D. student in Neuroscience (co-mentored by Graham Diering and Mark Shen).


Undergraduate Research Assistants

Tessa Buscher: Tessa is a sophomore at UNC-Chapel Hill majoring in Biology and Disability Studies. She assists with clinical study visits with children and infants.

Shaura Dave is a senior at UNC studying Neuroscience and Chemistry and works on MRI image processing and gene database curation.

Jonah Koenig is a senior at UNC studying Biology and Pre-Med and works on MRI image processing and gene database curation.

Yinuo (Noreen) Xu: Noreen is a sophomore at UNC-Chapel Hill studying Neuroscience, Psychology, and Health & Society. She assists with data management and data quality. Shen has an interest in working on sleep data.

Layla Niblock is a freshman at UNC and has an interest in working on Down syndrome projects.

Azreen Anwar is a freshman at UNC and has an interest in working on Down syndrome projects.

Yichi Zhang is a junior who joined us over the summer from Vanderbilt University and Yichi continues to work with us on various projects.


Collaborators

Ben Philpot, Ph.D. (UNC Kenan Distinguished Professor; Associate Director of the UNC Neuroscience Center) — Dr. Philpot’s lab seeks to understand the pathophysiology underlying monogenic neurodevelopmental disabilities, using this information to develop therapeutics to treat these disabilities. The Philpot lab is particularly focused on developing transformative treatments for Dup15q syndrome, Pitt-Hopkins syndrome, and Angelman syndrome. Dr. Philpot is Co-PI of Dr. Shen’s NIH-funded study of cerebrospinal fluid abnormalities (CSF) in neurodevelopmental disabilities.

Kathleen Caron, Ph.D. (UNC Professor and Chair of Cell Biology & Physiology) — Dr. Caron’s laboratory currently uses sophisticated gene targeting approaches to model human disease in mice. With a special emphasis on vascular biology and the lymphatic system, the Caron laboratory has gained valuable insights into the genetic basis and pathophysiology of lymphatic vascular disease, preeclampsia, and sex-dependent cardiovascular disease. Dr. Caron is a Co-Investigator of the Shen lab’s study of CSF abnormalities in neurodevelopmental disabilities.

Yen-Yu Ian Shih, Ph.D. (UNC Associate Professor of Neurology; Director of the Center for Animal MRI) — Dr. Shih's lab is interested in the use of electrophysiology, fiber-photometry, fast-scan cyclic voltammetry, optogenetics, chemogenetics, and electrical microstimulation in MRI environment, with a goal to understand how cellular activity and endogenous neurotransmission affect fMRI signals. His lab also pioneers new MRI methods for studying rodent models of human clinical disorders. Dr. Shih is a Co-Investigator of our study of CSF abnormalities in neurodevelopmental disabilities.

Martin Styner, Ph.D. (UNC Associate Professor of Computer Science and Psychiatry) — Dr. Styner has an extensive background in diffusion tensor imaging, anatomical structure and tissue segmentation, structural brain morphometry, and longitudinal imaging of brain development from birth through adulthood. He also has strong experience in image analysis of human, non-human primate, and rodent image analysis. Dr. Styner oversees medical imaging research projects in the field of neurodevelopment with applications to typical development, autism, fragile X syndrome, and schizophrenia. Dr. Styner is a Co-Investigator of our study of CSF abnormalities in neurodevelopmental disabilities.

Joe Piven, M.D. (UNC Thomas E. Castelloe Distinguished Professor of Psychiatry and Pediatrics) — Dr. Piven is Director of the Carolina Institute for Developmental Disabilities (CIDD), a comprehensive program of services, research, and training in neurodevelopmental disabilities. His research has emphasized interdisciplinary collaborations in imaging, behavioral-family, and genetics studies aimed at elucidating the pathogenesis of autistic syndromes. Dr. Piven is the PI of the Infant Brain Imaging Study (IBIS) Network, one of 10 NIH Autism Centers of Excellence in the U.S.

Heather Hazlett, Ph.D. (UNC Assistant Professor of Psychiatry) — Dr. Hazlett is a neuropsychologist whose primary research interests have focused on brain development in autism and fragile X syndrome, using brain MRI scans to conduct studies of brain structure and maturation. Her work involves the use of specialized image analysis tools to examine how brain development in children with autism and related disabilities compares to typical brain development. Dr. Hazlett is UNC site PI of IBIS.

Jessica Girault, Ph.D. (UNC Assistant Professor of Psychiatry) — Dr. Girault’s research utilizes state-of-the-art neuroimaging techniques and laboratory-based behavior assessments to study the dynamic interplay between brain and behavioral development during infancy and early childhood. A major focus of her work is to understand how brain-behavior associations across development are modulated by genetic factors.

Rebecca Grzadzinski, Ph.D. (UNC Assistant Professor of Psychiatry) — Dr. Grzadzinski is an Assistant Professor in the Department of Psychiatry with an appointment at the Carolina Institute for Developmental Disabilities. Her research examines the behavioral precursors of an autism spectrum disorder (ASD) diagnosis, changes in behaviors over time (e.g., treatment response), and the impact of child and family characteristics on child outcomes. Dr. Grzadzinski’s current research studies social communication skills and their brain correlates in children with Down Syndrome and/or ASD.

Jason Stein, Ph.D. (UNC Associate Professor of Genetics and Neuroscience) — The Stein lab studies how variations in the genome change the structure and development of the brain, and in doing so, create risk for neuropsychiatric illness. The Stein lab uses neural progenitor cells, a modifiable and high fidelity model system, as well as mouse models to understand how disease-associated variants affect brain development.  Dr. Stein collaborates with IBIS and the Shen lab to generate induced pluripotent stems cells (iPCS) donated by individuals with neurodevelopmental disabilities in our MRI studies — enabling the link between in vitro cellular and molecular mechanisms of prenatal brain development (iPSCs) and in vivo postnatal brain development (longitudinal infant MRIs).


Jeff Iliff, Ph.D. (University of Washington Professor of Neurology and Psychiatry) — Dr. Iliff led the team that initially characterized the glymphatic system, the network of perivascular pathways that supports the clearance of wastes from brain tissue during sleep. The Iliff lab is focused on defining the glial and vascular changes in the aging and post-traumatic brain that underlie impairment of glymphatic function and the vulnerability to the development of disorders like Alzheimer’s disease, Parkinson’s disease, and chronic traumatic encephalopathy. Dr. Iliff and Dr. Shen have been collaborators since 2019, and Dr. Iliff is the Consultant on Dr. Shen’s NIH-funded study of CSF abnormalities in neurodevelopmental disabilities.

Heather Volk, Ph.D., MPH (Johns Hopkins Associate Professor of Public Health) — Dr. Volk’s lab at Johns Hopkins University seeks to identify factors that relate to the risk and progression of neurodevelopmental disabilities. Her research interests include epidemiology, neurodevelopment, cognition, autism spectrum disorder, environment, prenatal exposure, gene-environment interaction, epigenetics, and air pollution. Dr. Volk is the Co-Investigator of our lab’s study to collect newborn bloodspots to link prenatal factors, immune system, and brain development in autism.

AJ Schwichtenberg, Ph.D. (Purdue University Associate Professor) — Dr. Schwichtenberg’s lab at Purdue University studies early ASD identification, sleep development in ASD, dyadic interactions in families raising children with ASD, sleep and at-risk development, and improving sleep assessment methods. Dr. Schwichtenberg is a Co-Investigator of our study of sleep problems in infants with neurodevelopmental disabilities.

Lab Alumni

  • Muskaan Khanna — School Psychology Ph.D. Student at UNC-Chapel Hill.

  • Cloie Dobias — Psychology Ph.D. student at Northeastern University.

  • Julia Gross — Current Project Development Specialist – Disability Advocacy, working with Deborah McFadden, former U.S. Commissioner of Disabilities.

  • Alexandra Bischak — Current graduate student in nursing at Xavier University 

  • Jessica Blanks — Current MD student at UNC School of Medicine 

  • Hayes Brenner — Current PhD student in Psychology at University of Connecticut 

  • Pearlynne Chong, Ph.D. — Completed Ph.D. in Human Development at Purdue University (co-mentored with A.J. Schwichtenberg)

  • Josephine Devanbu — Current neuroscience undergraduate at Brown University 

  • Kevin Donovan, Ph.D. — Current postdoctoral fellow at University of Pennsylvania  

  • Annie Gorges — Current D.V.M. student at NC State University 

  • Kayla Harrington, M.D. — Currently completing Pediatrics residency at Oakland Children’s Hospital 

  • Prasanna Kumar — Current M.D. student at University of Vermont Medical School 

  • Sarah Liston, M.D. — Currently completing Neurology residency at Wright State University 

  • Mahmoud Mostapha, Ph.D. — Research scientist at Siemens  

  • Veronica Murphy, Ph.D. — Completed Ph.D. in Neurobiology at UNC 

  • Rosio Sandoval — Graduated from UC Berkeley with a Doctor of Optometry  

  • Patricia Shih, M.A. — Current Ph.D. student in Neuroscience at Brown University 

  • Shannon Sweeney — Clinical research associate for industry clinical trials

  • Neha Wadhavkar — Current M.D. student at Rutgers University Medical School